Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Prohászka, Zoltán ^a   Munthe Fog, Lea ^b   Ueland, Thor ^c   Gombos, Timea ^a   Yndestad, Arne ^c   Förhécz, Zsolt ^a   Skjoedt, Mikkel Ole ^b   Pozsonyi, Zoltan ^a   Gustavsen, Alice ^c   Jánoskuti, Lívia ^a   Karádi, István ^a   Gullestad, Lars ^c   Dahl, Christen P ^c   Askevold, Erik T ^c   Füst, George ^a   Aukrust, Pål ^c   Mollnes, Tom E ^c   Garred, Peter ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; COMPLEMENT COMPONENT C3A; FICOLIN; FICOLIN 2; FICOLIN 3; LECTIN; MANNOSE BINDING LECTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; COMPLEMENT ACTIVATION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HUNGARIAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWEGIAN; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION;

AGED; CHRONIC DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; FEMALE; GLYCOPROTEINS; HEART FAILURE; HUMANS; LECTINS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84876172339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060976     Document Type: Article

References (34)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14: 803-869.
2. Wrigley BJ, Lip GY, Shantsila E, (2011) The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 13: 1161-1171.
3. Walport MJ, (2001) Complement. First of two parts. N Engl J Med 344: 1058-1066.
4. Aukrust P, Gullestad L, Lappegard KT, Ueland T, Aass H, et al. (2001) Complement activation in patients with congestive heart failure: effect of high-dose intravenous immunoglobulin treatment. Circulation 104: 1494-1500.
5. Clark DJ, Cleman MW, Pfau SE, Rollins SA, Ramahi TM, et al. (2001) Serum complement activation in congestive heart failure. Am Heart J 141: 684-690.
6. Gombos T, Forhecz Z, Pozsonyi Z, Szeplaki G, Kunde J, et al. (2012) Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure. Clin Res Cardiol 101: 605-615.
7. Zwaka TP, Manolov D, Ozdemir C, Marx N, Kaya Z, et al. (2002) Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. Am J Pathol 161: 449-457.
8. Zimmermann O, Kochs M, Zwaka TP, Bienek-Ziolkowski M, Hoher M, et al. (2007) Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy. Eur J Heart Fail 9: 51-54.
9. Garred P, Honore C, Ma YJ, Munthe-Fog L, Hummelshoj T, (2009) MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. Mol Immunol 46: 2737-2744.
10. Ma YJ, Skjoedt MO, Garred P (2012) Collectin-11:MASP complex formation triggers activation of the lectin complement pathway- the fifth lectin pathway initiation complex. J Innate Immun DOI: 10.1159/000345356.
11. Munthe-Fog L, Hummelshoj T, Ma YJ, Hansen BE, Koch C, et al. (2008) Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol 45: 2660-2666.
12. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, et al. (2007) The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 65: 383-392.
13. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, et al. (1992) Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 90: 517-521.
14. Honore C, Rorvig S, Munthe-Fog L, Hummelshoj T, Madsen HO, et al. (2008) The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol 45: 2782-2789.
15. Kaslow RA, Carrington M, Apple R, Park R, Munoz A, et al. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine 2: 405-411.
16. Krarup A, Wallis R, Presanis JS, Gal P, Sim RB, (2007) Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS ONE 2: e623.
17. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194: 781-795.
18. Nauta AJ, Raaschou-Jensen N, Roos A, Daha MR, Madsen HO, et al. (2003) Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 33: 2853-2863.
19. Lund Jensen M, Honore C, Hummelshoj T, Endel Hansen B, Madsen HO, et al. (2007) Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 44: 856-865.
20. Honore C, Hummelshoj T, Hansen BE, Madsen HO, Eggleton P, et al. (2007) The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum 56: 1598-1607.
21. Gout E, Garlatti V, Smith DF, Lacroix MM, Dumestre-Perard C, et al. (2010) Carbohydrate recognition properties of human ficolins: Glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem 285: 6612-6622.
22. Hein E, Honore C, Skjoedt MO, Munthe-Fog L, Hummelshoj T, et al. (2010) Functional analysis of Ficolin-3 mediated complement activation. PLoS ONE 5: e15443.
23. Whelan RS, Kaplinskiy V, Kitsis RN, (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72: 19-44.
24. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, et al. (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92: 715-724.
25. Oliveira GH, Brann CN, Becker K, Thohan V, Koerner MM, et al. (2006) Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium. Am J Cardiol 97: 1626-1629.
26. Hummelshoj T, Munthe-Fog L, Madsen HO, Sim RB, Garred P, (2008) Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol 45: 1623-1632.
27. Munthe-Fog L, Hummelshoj T, Honore C, Madsen HO, Permin H, et al. (2009) Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med 360: 2637-2644.
28. Imai N, Nishi S, Alchi B, Ueno M, Fukase S, et al. (2006) Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant 21: 2589-2595.
29. Bay JT, Hein E, Sørensen SS, Hansen JM, Garred P, (2013) Pre-transplant levels of ficolin-3 are associated with kidney graft survival. Clin Immunol 146: 240-247.
30. Wang CC, Yim KW, Poon TC, Choy KW, Chu CY, et al. (2007) Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem 53: 42-52.
31. Kim HJ, Cho EH, Yoo JH, Kim PK, Shin JS, et al. (2007) Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 6: 735-743.
32. Li RX, Chen HB, Tu K, Zhao SL, Zhou H, et al. (2008) Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS ONE 3: e3224.
33. Fust G, Munthe-Fog L, Illes Z, Szeplaki G, Molnar T, et al. (2011) Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic stroke. J Neuroinflammation 8: 185.
34. Garred P, Madsen HO, Kurtzhals JAL, Lamm LU, Thiel S, et al. (1992) Diallelic polymorphism may explain variations of blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenetics 19: 403-412.